表紙
市場調查報告書

肌肉萎縮性側索硬化症(ALS)市場報告 (2020-2030年):各治療方法 (藥物療法、幹細胞治療)、流通管道 (醫院藥局、零售藥局)、地區的預測,主要企業的簡介

Amyotrophic Lateral Sclerosis (ALS) Market Report 2020-2030: Forecasts by Treatment (Medication, Stem Cell Therapy, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), Geography, Profiles of Leading Companies

出版商 Visiongain Ltd 商品編碼 954221
出版日期 內容資訊 英文 207 Pages
商品交期: 最快1-2個工作天內
價格
肌肉萎縮性側索硬化症(ALS)市場報告 (2020-2030年):各治療方法 (藥物療法、幹細胞治療)、流通管道 (醫院藥局、零售藥局)、地區的預測,主要企業的簡介 Amyotrophic Lateral Sclerosis (ALS) Market Report 2020-2030: Forecasts by Treatment (Medication, Stem Cell Therapy, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), Geography, Profiles of Leading Companies
出版日期: 2020年06月22日內容資訊: 英文 207 Pages
簡介

全球肌肉萎縮性側索硬化症(ALS)的收益,估計2020年超越6億美元。在已開發國家與新興國家的雙方預計成長。根據分析,尤其是日本,法國,及中國,到2030年持續表現著達成盈利的高收益成長。

本報告提供全球肌肉萎縮性側索硬化症(ALS)市場相關調查,收益預測,近幾年的成果、成長率、市場佔有率,定性分析 (含市場動態,成長要素,機會,阻礙因素,課題),及主要企業簡介等資訊。

目錄

第1章 全球肌肉萎縮性側索硬化症(ALS)市場

  • 摘要整理
  • 為什麼要閱讀此報告
  • 本報告提供的東西
  • 這個分析報告回答的主要問題
  • 本報告的主要讀者為何?
  • 調查手法
  • 常見問題(FAQ)
  • 關聯的Visiongain報告
  • 關於Visiongain

第2章 肌肉萎縮性側索硬化症(ALS)市場簡介

  • 肌肉萎縮性側索硬化症(ALS)的簡介
    • 症狀
    • 診斷
  • 肌肉萎縮性側索硬化症(ALS)的市場區隔
    • 肌肉萎縮性側索硬化症(ALS)的市場區隔
    • 藥物療法
    • 幹細胞療法
    • 其他
    • 零售藥局
    • 醫院藥局
    • 其他

第3章 產業考察

  • 市場成長要素
    • 老年人口的增加
    • 在社區ALS支援相關意識提高
    • 開發平台&研究的增加
  • 市場阻礙因素/課題
    • 失敗的候補藥多數
  • 市場機會
    • 老年人口的比率最高的各國
  • 波特的五力分析

第4章 全球肌肉萎縮性側索硬化症(ALS)市場:各治療法

  • 次市場預測:藥物療法
    • 收益預測,V字型復甦
    • 收益預測,U字型復甦
    • 收益預測,W字型復甦
    • 收益預測,L字型復甦
  • 次市場預測:幹細胞療法
  • 次市場預測:其他

第5章 全球肌肉萎縮性側索硬化症(ALS)市場:各流通管道

  • 次市場預測:醫院藥局
    • 收益預測,V字型復甦
    • 收益預測,U字型復甦
    • 收益預測,W字型復甦
    • 收益預測,L字型復甦
  • 次市場預測:零售藥局
  • 次市場預測:其他

第6章 地區及主要國家的肌肉萎縮性側索硬化症(ALS)市場預測

  • 各國市場佔有率預測
  • 北美的肌肉萎縮性側索硬化症(ALS)預測
    • 北美:收益預測,V字型復甦
    • 北美:收益預測,U字型復甦
    • 北美:收益預測,W字型復甦
    • 北美:收益預測,L字型復甦
    • 美國的肌肉萎縮性側索硬化症(ALS)預測
    • 加拿大的肌肉萎縮性側索硬化症(ALS)預測
  • 歐洲的肌肉萎縮性側索硬化症(ALS)預測
    • 歐洲:收益預測,V字型復甦
    • 歐洲:收益預測,U字型復甦
    • 歐洲:收益預測,W字型復甦
    • 歐洲:收益預測,L字型復甦
    • 德國的肌肉萎縮性側索硬化症(ALS)預測
    • 英國肌肉萎縮性側索硬化症(ALS)預測
    • 法國的肌肉萎縮性側索硬化症(ALS)預測
    • 西班牙的肌肉萎縮性側索硬化症(ALS)預測
    • 義大利的肌肉萎縮性側索硬化症(ALS)預測
    • 其他歐洲的肌肉萎縮性側索硬化症(ALS)預測
  • 亞太地區的肌肉萎縮性側索硬化症(ALS)預測
    • 亞太地區:收益預測,V字型復甦
    • 亞太地區:收益預測,U字型復甦
    • 亞太地區:收益預測,W字型復甦
    • 日本的肌肉萎縮性側索硬化症(ALS)預測
    • 中國的肌肉萎縮性側索硬化症(ALS)預測
    • 印度的肌肉萎縮性側索硬化症(ALS)預測
    • 東南亞的肌肉萎縮性側索硬化症(ALS)預測
    • 其他亞太地區各國的肌肉萎縮性側索硬化症(ALS)預測
  • 其他 (ROW)
    • 其他:收益預測,V字型復甦
    • 其他:收益預測,U字型復甦
    • 其他:收益預測,W字型復甦
    • 其他:收益預測,L字型復甦

第7章 肌肉萎縮性側索硬化症(ALS)的主要企業

  • 市場佔有率分析 & FDA認證藥
  • 田邊三菱製藥
  • 大塚製藥
  • Biogen Inc
  • Corestem
  • AB Science
  • F.Hoffmann-La Roche AG
  • Sun Pharmaceutical
  • Ionis Pharmaceuticals, Inc
  • Amylyx Pharmaceuticals
  • BrainStorm Therapeutics

第8章 結論、建議

第9章 詞彙表

目錄
Product Code: PHA0785

Amyotrophic Lateral Sclerosis (ALS)-our new study reveals trends, R&D progress, Pipeline, and predicted revenues

Where is the Amyotrophic Lateral Sclerosis (ALS) market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 200+ page report provides 60+ tables, 150+ charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Amyotrophic Lateral Sclerosis (ALS) market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), material profiles and commercial developments, and Porters Five Forces.

Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market, there are 2 segmentations of the Amyotrophic Lateral Sclerosis (ALS) market, with forecasts for treatment and distribution channel each forecasted at a global and regional level.

Global Amyotrophic Lateral Sclerosis (ALS) Market by Treatment

  • Medication
  • Stem cell therapy
  • Others

Global Amyotrophic Lateral Sclerosis (ALS) Market by Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 13 leading national markets:

North America:

  • US
  • Canada

Europe:

  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe

Asia-Pacific:

  • Japan
  • China
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Rest of the World

Top Companies

  • Mitsubishi Tanabe Pharma Corporation
  • Otsuka Pharmaceutical Co., Ltd
  • Biogen Inc
  • Corestem
  • AB Science
  • F.Hoffmann-La Roche AG
  • Sun Pharmaceutical
  • Ionis Pharmaceuticals, Inc
  • Amylyx Pharmaceuticals
  • BrainStorm Therapeutics

The report also includes profiles and for some of the leading companies in the Amyotrophic Lateral Sclerosis (ALS) market, with a focus on this segment of these companies' operations.

There will be growth in both developed as well as emerging countries. Our analyses show that the both developed and developing markets, Japan, France, Japan, China in particular, will continue to achieve lucrative revenue growth to 2030.

Leading companies and the potential for market growth

Overall world revenue for Amyotrophic Lateral Sclerosis (ALS) will surpass $600 million in 2020, our work calculates. We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Amyotrophic Lateral Sclerosis (ALS) Market report helps you

In summary, our 200+ page report provides you with the following knowledge:
  • Revenue forecasts to 2030 for 2 segmentations of the Amyotrophic Lateral Sclerosis (ALS) market, with forecasts for Treatment and Distribution Channel each forecasted at a global and regional level- discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2030 for 4 regional and 13 key national markets - See forecasts for the Amyotrophic Lateral Sclerosis (ALS) market in North America, Europe, Asia-Pacific, and Rest of the World, Also forecasted is the market in the U.S., Canada, Germany, France, UK, Italy, France, Spain, China, India, Japan, and Southeast Asia.
  • Prospects for established firms and those seeking to enter the market- including company profiles for 10 of the major companies involved in the Amyotrophic Lateral Sclerosis (ALS) market

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain's study is for everybody needing commercial analyses for the Amyotrophic Lateral Sclerosis (ALS) market and leading companies. You will find data, trends and predictions.

Buy our report today Amyotrophic Lateral Sclerosis (ALS) Market Report 2020-2030: Forecasts by Treatment (Medication, Stem Cell Therapy, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), and Geography PLUS Profiles of Leading Companies. Avoid missing out by staying informed - order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1 Global Amyotrophic Lateral Sclerosis (ALS) Market 2020-2030

  • 1.1 Executive Summary
  • 1.2 Why You Should Read This Report
  • 1.3 What This Report Delivers
  • 1.4 Key Questions Answered by This Analytical Report Include:
  • 1.5 Who is This Report For?
  • 1.6 Methodology
  • 1.7 Frequently Asked Questions (FAQs)
  • 1.8 Associated Visiongain Reports
  • 1.9 About Visiongain

2 Introduction to the Amyotrophic Lateral Sclerosis (ALS) Market

  • 2.1 Introduction to the Amyotrophic Lateral Sclerosis (ALS)
    • 2.1.1 Symptoms
    • 2.1.2 Diagnosis
  • 2.2 Amyotrophic Lateral Sclerosis (ALS) Segmentation
    • 2.2.1 Amyotrophic Lateral Sclerosis (ALS) Segmentation
    • 2.2.2 Medication
    • 2.2.3 Stem cell therapy
    • 2.2.4 Others
    • 2.2.5 Retail Pharmacies
    • 2.2.6 Hospital Pharmacies
    • 2.2.7 Others

3 Industry Insights

  • 3.1 Market Drivers
    • 3.1.1 Increasing geriatric population
    • 3.1.2 Increasing awareness regarding ALS support in the community
    • 3.1.3 Increasing pipeline and research
  • 3.2 Market Restraints/Challenges
    • 3.2.1 Large number of failed trial candidates
  • 3.3 Market Opportunities
    • 3.3.1 Countries with highest ratio of geriatric population
  • 3.4 Porter's five forces
    • 3.4.1 Bargaining Power of Buyers (Low)
    • 3.4.2 Bargaining Power of Suppliers (High)
    • 3.4.3 Threat of Substitutes
    • 3.4.4 Threat of New Entrants
    • 3.4.5 Industry Rivalry

4 Global Amyotrophic Lateral Sclerosis (ALS) Market by Treatment

  • 4.1 Medication Submarket Forecast 2020-2030
    • 4.1.1 Global ALS Market for Medication Segment: Revenue Forecast, V Shaped Recovery
    • 4.1.2 Global ALS Market for Medication Segment: Revenue Forecast, U Shaped Recovery
    • 4.1.3 Global ALS Market for Medication Segment: Revenue Forecast, W Shaped Recovery
    • 4.1.4 Global ALS Market for Medication Segment: Revenue Forecast, L Shaped Recovery
  • 4.2 Stem Cell Therapy Submarket Forecast 2020-2030
    • 4.2.1 Global ALS Market for Stem Cell Therapy Segment: Revenue Forecast, V Shaped Recovery
    • 4.2.2 Global ALS Market for Stem Cell Therapy Segment: Revenue Forecast, U Shaped Recovery
    • 4.2.3 Global ALS Market for Stem Cell Therapy Segment: Revenue Forecast, W Shaped Recovery
    • 4.2.4 Global ALS Market for Stem Cell Therapy Segment: Revenue Forecast, L Shaped Recovery
  • 4.3 Others Submarket Forecast 2020-2030
    • 4.3.1 Global ALS Market for Others Segment: Revenue Forecast, V Shaped Recovery
    • 4.3.2 Global ALS Market for Others Segment: Revenue Forecast, W Shaped Recovery
    • 4.3.3 Global ALS Market for Others Segment: Revenue Forecast, W Shaped Recovery
    • 4.3.4 Global ALS Market for Others Segment: Revenue Forecast, L Shaped Recovery

5 Global Amyotrophic Lateral Sclerosis (ALS) Market by Distribution Channel

  • 5.1 Hospital Pharmacies Submarket Forecast 2020-2030
    • 5.1.1 Global ALS Market for Hospital Pharmacies Segment: Revenue Forecast, V Shaped Recovery
    • 5.1.2 Global ALS Market for Hospital Pharmacies Segment: Revenue Forecast, U Shaped Recovery
    • 5.1.3 Global ALS Market for Hospital Pharmacies Segment: Revenue Forecast, W Shaped Recovery
    • 5.1.4 Global ALS Market for Hospital Pharmacies Segment: Revenue Forecast: L Shaped Recovery
  • 5.2 Retail Pharmacies Submarket Forecast 2020-2030
    • 5.2.1 Global ALS Market for Retail Pharmacies Segment: Revenue Forecast, V Shaped Recovery
    • 5.2.2 Global ALS Market for Retail Pharmacies Segment: Revenue Forecast, U Shaped Recovery
    • 5.2.3 Global ALS Market for Retail Pharmacies Segment: Revenue Forecast, W Shaped Recovery
    • 5.2.4 Global ALS Market for Retail Pharmacies Segment: Revenue Forecast, L Shaped Recovery
  • 5.3 Others Submarket Forecast 2020-2030
    • 5.3.1 Global ALS Market for Others Segment: Revenue Forecast, V Shaped Recovery
    • 5.3.2 Global ALS Market for Others Segment: Revenue Forecast, U Shaped Recovery
    • 5.3.3 Global ALS Market for Others Segment: Revenue Forecast, W Shaped Recovery
    • 5.3.4 Global ALS Market for Others Segment: Revenue Forecast, L Shaped Recovery

6 Regional and Leading National Amyotrophic Lateral Sclerosis (ALS) Forecasts 2020-2030

  • 6.1 Global Amyotrophic Lateral Sclerosis (ALS) by National Market Share Forecast 2020-2030
  • 6.2 North America Amyotrophic Lateral Sclerosis (ALS) Forecast 2020-2030
    • 6.2.1 North America ALS Market: Revenue Forecast, V Shaped Recovery
    • 6.2.2 North America ALS Market: Revenue Forecast, U Shaped Recovery
    • 6.2.3 North America ALS Market: Revenue Forecast, W Shaped Recovery
    • 6.2.4 North America ALS Market: Revenue Forecast, L Shaped Recovery
    • 6.2.5 U.S. Amyotrophic Lateral Sclerosis (ALS) Forecast 2020-2030
      • 6.2.5.1 U.S. ALS Market: Revenue Forecast, V Shaped Recovery
      • 6.2.5.2 U.S. ALS Market: Revenue Forecast, U Shaped Recovery
      • 6.2.5.3 U.S. ALS Market: Revenue Forecast, W Shaped Recovery
      • 6.2.5.4 U.S. ALS Market: Revenue Forecast, L Shaped Recovery
    • 6.2.6 Canada Amyotrophic Lateral Sclerosis (ALS) Forecast 2020-2030
    • 6.2.6.1 Canada ALS Market: Revenue Forecast, V Shaped Recovery
    • 6.2.6.2 Canada ALS Market: Revenue Forecast, U Shaped Recovery
    • 6.2.6.3 Canada ALS Market: Revenue Forecast, W Shaped Recovery
    • 6.2.6.4 Canada ALS Market: Revenue Forecast, L Shaped Recovery
  • 6.3 Europe Amyotrophic Lateral Sclerosis (ALS) Forecast 2020-2030
    • 6.3.1 Europe ALS Market: Revenue Forecast, V Shaped Recovery
    • 6.3.2 Europe ALS Market: Revenue Forecast, U Shaped Recovery
    • 6.3.3 Europe ALS Market: Revenue Forecast, W Shaped Recovery
    • 6.3.4 Europe ALS Market: Revenue Forecast, L Shaped Recovery
    • 6.3.5 Germany Amyotrophic Lateral Sclerosis (ALS) Forecast 2020-2030
      • 6.3.5.1 Germany ALS Market: Revenue Forecast, V Shaped Recovery
      • 6.3.5.2 Germany ALS Market: Revenue Forecast, U Shaped Recovery
      • 6.3.5.3 Germany ALS Market: Revenue Forecast, W Shaped Recovery
      • 6.3.5.4 Germany ALS Market: Revenue Forecast, L Shaped Recovery
    • 6.3.6 UK Amyotrophic Lateral Sclerosis (ALS) Forecast 2020-2030
      • 6.3.6.1 UK ALS Market: Revenue Forecast, V Shaped Recovery
      • 6.3.6.2 UK ALS Market: Revenue Forecast, U Shaped Recovery
      • 6.3.6.3 UK ALS Market: Revenue Forecast, W Shaped Recovery
      • 6.3.6.4 UK ALS Market: Revenue Forecast, L Shaped Recovery
    • 6.3.7 France Amyotrophic Lateral Sclerosis (ALS) Forecast 2020-2030
      • 6.3.7.1 France ALS Market: Revenue Forecast, V Shaped Recovery
      • 6.3.7.2 France ALS Market: Revenue Forecast, U Shaped Recovery
      • 6.3.7.3 France ALS Market: Revenue Forecast, W Shaped Recovery
      • 6.3.7.4 France ALS Market: Revenue Forecast, L Shaped Recovery
    • 6.3.8 Spain Amyotrophic Lateral Sclerosis (ALS) Forecast 2020-2030
      • 6.3.8.1 Spain ALS Market: Revenue Forecast, V Shaped Recovery
      • 6.3.8.2 Spain ALS Market: Revenue Forecast, U Shaped Recovery
      • 6.3.8.3 Spain ALS Market: Revenue Forecast, W Shaped Recovery
      • 6.3.8.4 Spain ALS Market: Revenue Forecast, L Shaped Recovery
    • 6.3.9 Italy Amyotrophic Lateral Sclerosis (ALS) Forecast 2020-2030
      • 6.3.9.1 Italy ALS Market: Revenue Forecast, V Shaped Recovery
      • 6.3.9.2 Italy ALS Market: Revenue Forecast, U Shaped Recovery
      • 6.3.9.3 Italy ALS Market: Revenue Forecast, W Shaped Recovery
      • 6.3.9.4 Italy ALS Market: Revenue Forecast, L Shaped Recovery
    • 6.3.10 Rest of Europe Amyotrophic Lateral Sclerosis (ALS) Forecast 2020-2030
      • 6.3.10.1 Rest of Europe ALS Market: Revenue Forecast, V Shaped Recovery
      • 6.3.10.2 Rest of Europe ALS Market: Revenue Forecast, U Shaped Recovery
      • 6.3.10.3 Rest of Europe ALS Market: Revenue Forecast, W Shaped Recovery
      • 6.3.10.4 Rest of Europe ALS Market: Revenue Forecast, L Shaped Recovery
  • 6.4 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Forecast 2020-2030
    • 6.4.1 Asia Pacific ALS Market: Revenue Forecast, V Shaped Recovery
    • 6.4.2 Asia Pacific ALS Market: Revenue Forecast, U Shaped Recovery
    • 6.4.3 Asia Pacific ALS Market: Revenue Forecast, W Shaped Recovery
    • 6.4.4 Japan Amyotrophic Lateral Sclerosis (ALS) Forecast 2020-2030
      • 6.4.4.1 Japan ALS Market: Revenue Forecast, V Shaped Recovery
      • 6.4.4.2 Japan ALS Market: Revenue Forecast, U Shaped Recovery
      • 6.4.4.3 Japan ALS Market: Revenue Forecast, W Shaped Recovery
      • 6.4.4.4 Japan ALS Market: Revenue Forecast, L Shaped Recovery
    • 6.4.5 China Amyotrophic Lateral Sclerosis (ALS) Forecast 2020-2030
      • 6.4.5.1 China ALS Market: Revenue Forecast, V Shaped Recovery
      • 6.4.5.2 China ALS Market: Revenue Forecast, U Shaped Recovery
      • 6.4.5.3 China ALS Market: Revenue Forecast, W Shaped Recovery
      • 6.4.5.4 China ALS Market: Revenue Forecast, L Shaped Recovery
    • 6.4.6 India Amyotrophic Lateral Sclerosis (ALS) Forecast 2020-2030
      • 6.4.6.1 India ALS Market: Revenue Forecast, V Shaped Recovery
      • 6.4.6.2 India ALS Market: Revenue Forecast, U Shaped Recovery
      • 6.4.6.3 India ALS Market: Revenue Forecast, W Shaped Recovery
      • 6.4.6.4 India ALS Market: Revenue Forecast, L Shaped Recovery
    • 6.4.7 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Forecast 2020-2030
      • 6.4.7.1 Southeast Asia ALS Market: Revenue Forecast, V Shaped Recovery
      • 6.4.7.2 Southeast Asia ALS Market: Revenue Forecast, U Shaped Recovery
      • 6.4.7.3 Southeast Asia ALS Market: Revenue Forecast, W Shaped Recovery
      • 6.4.7.4 Southeast Asia ALS Market: Revenue Forecast, L Shaped Recovery
    • 6.4.8 Rest of APAC Amyotrophic Lateral Sclerosis (ALS) Forecast 2020-2030
      • 6.4.8.1 Rest of Asia Pacific ALS Market: Revenue Forecast, V Shaped Recovery
      • 6.4.8.2 Rest of Asia Pacific ALS Market: Revenue Forecast, U Shaped Recovery
      • 6.4.8.3 Rest of Asia Pacific ALS Market: Revenue Forecast, W Shaped Recovery
      • 6.4.8.4 Rest of Asia Pacific ALS Market: Revenue Forecast, L Shaped Recovery
  • 6.5 Rest of the World Amyotrophic Lateral Sclerosis (ALS) Forecast 2020-2030
    • 6.5.1 Rest of the World ALS Market: Revenue Forecast, V Shaped Recovery
    • 6.5.2 Rest of the World ALS Market: Revenue Forecast, U Shaped Recovery
    • 6.5.3 Rest of the World ALS Market: Revenue Forecast, W Shaped Recovery
    • 6.5.4 Rest of the World ALS Market: Revenue Forecast, L Shaped Recovery

7 Leading Companies in the Amyotrophic Lateral Sclerosis (ALS)

  • 7.1 Market Share Analysis & FDA-Approved Drugs
    • 7.1.1 Radicava (Mitsubishi Tanabe Pharma America)
    • 7.1.2 Rilutek, (Generic)
    • 7.1.3 Tiglutik
    • 7.1.4 Nuedexta
  • 7.2 Mitsubishi Tanabe Pharma Corporation
    • 7.2.1 Total Company Sales (US$ million) 2016 -2019
    • 7.2.2 Products / Services
    • 7.2.3 Mergers & Acquisitions (M&A) Activity
  • 7.3 Otsuka Pharmaceutical Co., Ltd
    • 7.3.1 Total Company Sales (US$ million) 2016 - 2019
    • 7.3.2 Products / Services
  • 7.4 Biogen Inc
    • 7.4.1 Total Company Sales (US$ million) 2016 - 2019
    • 7.4.2 Products / Services
  • 7.5 Corestem
    • 7.5.1 Total Company Sales (US$ million) 2016 - 2019
    • 7.5.2 Products / Services
  • 7.6 AB Science
    • 7.6.1 Total Company Sales (US$ million) 2016 - 2018
    • 7.6.2 Products / Services
    • 7.6.3 New Drug Approvals
  • 7.7 F.Hoffmann-La Roche AG
    • 7.7.1 Total Company Sales (US$ million) 2016 - 2019
    • 7.7.2 Products / Services
  • 7.8 Sun Pharmaceutical
    • 7.8.1 Total Company Sales (US$ million) 2016 - 2019
    • 7.8.2 Products / Services
  • 7.9 Ionis Pharmaceuticals, Inc
    • 7.9.1 Total Company Sales (US$ million) 2016 - 2019
    • 7.9.2 Products / Services
    • 7.9.3 New Drug Developments & Approvals
  • 7.10 Amylyx Pharmaceuticals
    • 7.10.1 Products / Services
    • 7.10.2 New Drug Developments & Approvals
  • 7.11 BrainStorm Therapeutics
    • 7.11.1 Products / Services
    • 7.11.2 New Drug Developments & Approvals

8 Conclusions and Recommendations

9 Glossary

  • Appendix A: About Visiongain
  • Appendix B: Visiongain report evaluation form

List of Figures

  • Table 1 Global Allergic Rhinitis Drugs Market, 2019-2030 (US$ million, CAGR %)
  • Table 2 Global Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 3 Intranasal Antihistamines Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 4 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 5 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 6 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 7 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 8 Dymista Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 9 Generic Intranasal Azelastine Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 10 Astepro Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 11 Patanase Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 12 Astelin Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 13 Others Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 14 Intranasal Corticosteroids Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 15 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 16 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 17 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 18 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 19 Flixonase/Flonase/Flonase OTC Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 20 Nasonex Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 21 Avamys/Veramyst Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 22 Rhinocort Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 23 Nasacort/Nasacort-OTC Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 24 Omnaris Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 25 Beconase/Beconaes AQ Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 26 Qnasl Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 27 Zetonna Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 28 Others Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 29 Oral Antihistamines Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 30 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Oral Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 31 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Oral Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 32 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Oral Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 33 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Oral Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 34 Allegra/Allegra-D/Allegra OTC Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 35 Claritin/Claritin OTC Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 36 Zyrtec/Zyrtec D Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 37 Xyzal Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 38 Clarinex Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 39 Allelock Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 40 Ebastel Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 41 Talion Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 42 Others Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 43 Immunotherapy and Vaccines Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 44 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Immunotherapy and Vaccines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 45 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Immunotherapy and Vaccines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 46 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Immunotherapy and Vaccines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 47 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Immunotherapy and Vaccines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 48 Staloral Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 49 Alutard SQ Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 50 Grazax/Grastek Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 51 Oralair Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 52 Ragwitek Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 53 Others Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 54 Others Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 55 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 56 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 57 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 58 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 59 Global Allergic Rhinitis Drugs Market CAGR Forecast by Region 2020, 2025, 2030 (%)
  • Table 60 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market Forecast by Region, 2020- 2030 (US$ million, AGR %,)
  • Table 61 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market Forecast by Region, 2020- 2030 (US$ million, AGR %,)
  • Table 62 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market Forecast by Region, 2020- 2030 (US$ million, AGR %,)
  • Table 63 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market Forecast by Region, 2020- 2030 (US$ million, AGR %,)
  • Table 64 "V" Shaped Recovery: North America Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 65 "U" Shaped Recovery: North America Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 66 "W" Shaped Recovery: North America Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 67 "L" Shaped Recovery: North America Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 68 North America Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR %)
  • Table 69 North America Allergic Rhinitis Drugs Market by Sub Markets: CAGR% (2020-2025, 2025-2030, 2020-2030)
  • Table 70 "V" Shaped Recovery: North America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 71 "U" Shaped Recovery: North America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 72 "W" Shaped Recovery: North America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 73 "L" Shaped Recovery: North America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 74 U.S. Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 75 "V" Shaped Recovery: U.S. Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 76 "U" Shaped Recovery: U.S. Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 77 "W" Shaped Recovery: U.S. Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 78 "L" Shaped Recovery: U.S. Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 79 Canada Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 80 "V" Shaped Recovery: Canada Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 81 "U" Shaped Recovery: Canada Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 82 "W" Shaped Recovery: Canada Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 83 "L" Shaped Recovery: Canada Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 84 "V" Shaped Recovery: Europe Allergic Rhinitis Drugs Market Forecast by Country, 2020- 2030 (US$ million, AGR %,)
  • Table 85 "U" Shaped Recovery: Europe Allergic Rhinitis Drugs Market Forecast by Country, 2020- 2030 (US$ million, AGR %,)
  • Table 86 "W" Shaped Recovery: Europe Allergic Rhinitis Drugs Market Forecast by Country, 2020- 2030 (US$ million, AGR %,)
  • Table 87 "L" Shaped Recovery: Europe Allergic Rhinitis Drugs Market Forecast by Country, 2020- 2030 (US$ million, AGR %,)
  • Table 88 Europe Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR %)
  • Table 89 Europe Allergic Rhinitis Drugs Market by Sub Markets: CAGR% (2020-2025, 2025-2030, 2020-2030)
  • Table 90 "V" Shaped Recovery: Europe Allergic Rhinitis Market Forecast by Sub-Markets, 2020- 2030 (US$ million, AGR %, CAGR%)
  • Table 91 "U" Shaped Recovery: Europe Allergic Rhinitis Market Forecast by Sub-Markets, 2020- 2030 (US$ million, AGR %, CAGR%)
  • Table 92 "W" Shaped Recovery: Europe Allergic Rhinitis Market Forecast by Sub-Markets, 2020- 2030 (US$ million, AGR %, CAGR%)
  • Table 93 "L" Shaped Recovery: Europe Allergic Rhinitis Market Forecast by Sub-Markets, 2020- 2030 (US$ million, AGR %, CAGR%)
  • Table 94 Germany Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 95 "V" Shaped Recovery: Germany Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 96 "U" Shaped Recovery: Germany Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 97 "W" Shaped Recovery: Germany Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 98 "L" Shaped Recovery: Germany Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 99 UK Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 100 "V" Shaped Recovery: UK Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 101 "U" Shaped Recovery: UK Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 102 "W" Shaped Recovery: UK Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 103 "L" Shaped Recovery: UK Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 104 France Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 105 "V" Shaped Recovery: France Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 106 "U" Shaped Recovery: France Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 107 "W" Shaped Recovery: France Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 108 "L" Shaped Recovery: France Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 109 Italy Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 110 "V" Shaped Recovery: Italy Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 111 "U" Shaped Recovery: Italy Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 112 "W" Shaped Recovery: Italy Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 113 "L" Shaped Recovery: Italy Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 114 Spain Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 115 "V" Shaped Recovery: Spain Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 116 "U" Shaped Recovery: Spain Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 117 "W" Shaped Recovery: Spain Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 118 "L" Shaped Recovery: Spain Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 119 Belgium Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 120 "V" Shaped Recovery: Belgium Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 121 "U" Shaped Recovery: Belgium Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 122 "W" Shaped Recovery: Belgium Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 123 "L" Shaped Recovery: Belgium Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 124 Switzerland Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 125 "V" Shaped Recovery: Switzerland Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 126 "U" Shaped Recovery: Switzerland Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 127 "W" Shaped Recovery: Switzerland Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 128 "L" Shaped Recovery: Switzerland Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 129 Rest of Europe Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 130 "V" Shaped Recovery: Rest of Europe Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 131 "U" Shaped Recovery: Rest of Europe Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 132 "W" Shaped Recovery: Rest of Europe Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 133 "L" Shaped Recovery: Rest of Europe Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 134 "V" Shaped Recovery: Asia Pacific Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 135 "U" Shaped Recovery: Asia Pacific Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 136 "W" Shaped Recovery: Asia Pacific Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 137 "L" Shaped Recovery: Asia Pacific Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 138 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR %)
  • Table 139 Asia Pacific Allergic Rhinitis Drugs Market by Sub Markets: CAGR% (2020-2025, 2025-2030, 2020-2030)
  • Table 140 "V" Shaped Recovery: Asia Pacific Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 141 "U" Shaped Recovery: Asia Pacific Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 142 "W" Shaped Recovery: Asia Pacific Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 143 "L" Shaped Recovery: Asia Pacific Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 144 Japan Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 145 "V" Shaped Recovery: Japan Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 146 "U" Shaped Recovery: Japan Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 147 "W" Shaped Recovery: Japan Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 148 "L" Shaped Recovery: Japan Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 149 China Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 150 "V" Shaped Recovery: China Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 151 "U" Shaped Recovery: China Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 152 "W" Shaped Recovery: China Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 153 "L" Shaped Recovery: China Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 154 India Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 155 "V" Shaped Recovery: India Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 156 "U" Shaped Recovery: India Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 157 "W" Shaped Recovery: India Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 158 "L" Shaped Recovery: India Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 159 Rest of Asia Pacific Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 160 "V" Shaped Recovery: Rest of Asia Pacific Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 161 "U" Shaped Recovery: Rest of Asia Pacific Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 162 "W" Shaped Recovery: Rest of Asia Pacific Allergic Rhinitis Market Forecast 2020- 2030 (US$ million, AGR %, CAGR %)
  • Table 163 "L" Shaped Recovery: Rest of Asia Pacific Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 164 "V" Shaped Recovery: Latin America Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 165 "U" Shaped Recovery: Latin America Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 166 "W" Shaped Recovery: Latin America Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 167 "L" Shaped Recovery: Latin America Allergic Rhinitis Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %,)
  • Table 168 Latin America Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR %)
  • Table 169 Latin America Allergic Rhinitis Drugs Market by Sub Markets: CAGR% (2020-2025, 2025-2030, 2020-2030)
  • Table 170 "V" Shaped Recovery: Latin America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 171 "U" Shaped Recovery: Latin America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 172 "W" Shaped Recovery: Latin America Allergic Rhinitis Market Forecast by Sub- Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 173 "L" Shaped Recovery: Latin America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 174 Brazil Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 175 "V" Shaped Recovery: Brazil Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 176 "U" Shaped Recovery: Brazil Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 177 "W" Shaped Recovery: Brazil Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 178 "L" Shaped Recovery: Brazil Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 179 Mexico Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 180 "V" Shaped Recovery: Mexico Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 181 "U" Shaped Recovery: Mexico Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 182 "W" Shaped Recovery: Mexico Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 183 "L" Shaped Recovery: Mexico Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 184 Argentina Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 185 "V" Shaped Recovery: Argentina Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 186 "U" Shaped Recovery: Argentina Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 187 "W" Shaped Recovery: Argentina Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 188 "L" Shaped Recovery: Argentina Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 189 Rest of Latin America Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 190 "V" Shaped Recovery: Rest of Latin America Allergic Rhinitis Market Forecast 2020- 2030 (US$ million, AGR %, CAGR %)
  • Table 191 "U" Shaped Recovery: Rest of Latin America Allergic Rhinitis Market Forecast 2020- 2030 (US$ million, AGR %, CAGR %)
  • Table 192 "W" Shaped Recovery: Rest of Latin America Allergic Rhinitis Market Forecast 2020- 2030 (US$ million, AGR %, CAGR %)
  • Table 193 "L" Shaped Recovery: Rest of Latin America Allergic Rhinitis Market Forecast 2020- 2030 (US$ million, AGR %, CAGR %)
  • Table 194 "V" Shaped Recovery: MEA Allergic Rhinitis Drugs Market Forecast by Country, 2020- 2030 (US$ million, AGR %,)
  • Table 195 "U" Shaped Recovery: MEA Allergic Rhinitis Drugs Market Forecast by Country, 2020- 2030 (US$ million, AGR %,)
  • Table 196 "W" Shaped Recovery: MEA Allergic Rhinitis Drugs Market Forecast by Country, 2020- 2030 (US$ million, AGR %,)
  • Table 197 "L" Shaped Recovery: MEA Allergic Rhinitis Drugs Market Forecast by Country, 2020- 2030 (US$ million, AGR %,)
  • Table 198 MEA Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR %)
  • Table 199 MEA Allergic Rhinitis Drugs Market by Sub Markets: CAGR% (2020-2025, 2025-2030, 2020-2030)
  • Table 200 "V" Shaped Recovery: Middle East and Africa Allergic Rhinitis Market Forecast by Sub- Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 201 "U" Shaped Recovery: Middle East and Africa Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 202 "W" Shaped Recovery: Middle East and Africa Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 203 "L" Shaped Recovery: Middle East and Africa Allergic Rhinitis Market Forecast by Sub- Markets, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 204 UAE Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 205 "V" Shaped Recovery: UAE Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 206 "U" Shaped Recovery: UAE Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 207 "W" Shaped Recovery: UAE Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 208 "L" Shaped Recovery: UAE Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 209 Saudi Arabia Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 210 "V" Shaped Recovery: Saudi Arabia Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 211 "U" Shaped Recovery: Saudi Arabia Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 212 "W" Shaped Recovery: Saudi Arabia Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 213 "L" Shaped Recovery: Saudi Arabia Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 214 South Africa Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 215 "V" Shaped Recovery: South Africa Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 216 "U" Shaped Recovery: South Africa Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 217 "W" Shaped Recovery: South Africa Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 218 "L" Shaped Recovery: South Africa Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 219 Rest of MEA Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 220 "V" Shaped Recovery: Rest of Middle East and Africa Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 221 "U" Shaped Recovery: Rest of Middle East and Africa Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 222 "W" Shaped Recovery: Rest of Middle East and Africa Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 223 "L" Shaped Recovery: Rest of Middle East and Africa Allergic Rhinitis Market Forecast 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 224 ALK-Abello A/S: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 225 ALK-Abello A/S: Financials, 2015-2019 (DKK million, AGR %)
  • Table 226 GSK: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 227 GSK: Financials, 2015-2019 (US$ million, AGR %)
  • Table 228 Johnson & Johnson: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 229 Johnson & Johnson: Financials, 2015-2019 (US$ million, AGR %)
  • Table 230 Kyowa Hakko Kirin: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 231 Kyowa Hakko Kirin: Financials, 2015-2019 (millions of yen, AGR %)
  • Table 232 Merck KGaA: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 233 Merck KGaA: Financials, 2015-2019 (? million, AGR %)
  • Table 234 Sanofi: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 235 Sanofi: Financials, 2015-2019 (? million, AGR %)
  • Table 236 Stallergenes Greer: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 237 Stallergenes Greer: Financials, 2015-2019 (? million, AGR %)
  • Table 238 UCB S.A.: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 239 UCB S.A.: Financials, 2015-2019 (? million, AGR %)
  • Table 240 Boehringer Ingelheim International GmbH: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 241 Boehringer Ingelheim International GmbH: Financials, 2015-2019 (? million, AGR %)
  • Table 242 Bayer AG: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 243 Bayer AG: Financials, 2015-2019 (? million, AGR %)
  • Table 244 Novartis AG: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 245 Novartis AG: Financials, 2015-2019 (US$ million, AGR %)
  • Table 246 AstraZeneca: Key Details (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 247 AstraZeneca: Financials, 2015-2019 (US$ million, AGR %)
  • Table 248 Global Allergic Rhinitis Drugs Market CAGR Forecast by Region 2020, 2025, 2030 (%)

List of Figures

  • Figure 1 Global Allergic Rhinitis Drugs Market Segmentation
  • Figure 2 Role of Mast Cells and IgE in Allergic Rhinitis
  • Figure 3 Leading Antihistamines for Allergic Rhinitis
  • Figure 4 Leading Corticosteroids for Allergic Rhinitis,
  • Figure 5 Global Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR %)
  • Figure 6 Global Allergic Rhinitis Drugs Market Share Forecast by Sub Markets, 2020, 2025, 2030 (%)
  • Figure 7 Intranasal Antihistamines Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 8 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 9 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 10 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 11 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 12 Dymista Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 13 Generic Intranasal Azelastine Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 14 Astepro Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 15 Patanase Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 16 Astelin Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 17 Others Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 18 Intranasal Corticosteroids Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 19 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 20 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 21 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 22 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Intranasal Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 23 Flixonase/Flonase/Flonase OTC Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 24 Nasonex Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 25 Avamys/Veramyst Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 26 Rhinocort Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 27 Nasacort/Nasacort-OTC Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 28 Omnaris Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 29 Beconase/Beconaes AQ Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 30 Qnasl Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 31 Zetonna Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 32 Others Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 33 Oral Antihistamines Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 34 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Oral Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 35 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Oral Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 36 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Oral Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 37 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Oral Antihistamines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 38 Allegra/Allegra-D/Allegra OTC Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 39 Claritin/Claritin OTC Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 40 Zyrtec/Zyrtec D Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 41 Xyzal Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 42 Clarinex Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 43 Allelock Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 44 Ebastel Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 45 Talion Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 46 Others Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 47 Immunotherapy and Vaccines Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 48 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Immunotherapy and Vaccines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 49 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Immunotherapy and Vaccines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 50 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Immunotherapy and Vaccines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 51 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Immunotherapy and Vaccines Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 52 Staloral Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 53 Alutard SQ Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 54 Grazax/Grastek Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 55 Oralair Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 56 Ragwitek Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 57 Others Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 58 Others Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 59 "V" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 60 "U" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 61 "W" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 62 "L" Shaped Recovery: Global Allergic Rhinitis Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 63 Global Allergic Rhinitis Drugs Market Forecast by Region 2020-2030 (US$ million, AGR %)
  • Figure 64 Global Allergic Rhinitis Drugs Market Share Forecast by Region 2020, 2025, 2030 (%)
  • Figure 65 North America Allergic Rhinitis Drugs Market Forecast by Country 2020-2030 (US$ million, AGR %)
  • Figure 66 North America Allergic Rhinitis Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 67 North America Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR%)
  • Figure 68 "V" Shaped Recovery: North America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 69 "U" Shaped Recovery: North America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 70 "W" Shaped Recovery: North America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 71 "L" Shaped Recovery: North America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 72 U.S. Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 73 "V" Shaped Recovery: U.S. Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 74 "U" Shaped Recovery: U.S. Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 75 "W" Shaped Recovery: U.S. Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 76 "L" Shaped Recovery: U.S. Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 77 Canada Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 78 "V" Shaped Recovery: Canada Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 79 "U" Shaped Recovery: Canada Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 80 "W" Shaped Recovery: Canada Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 81 "L" Shaped Recovery: Canada Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 82 Europe Allergic Rhinitis Drugs Market Forecast by Country 2020-2030 (US$ million, AGR %)
  • Figure 83 Europe Allergic Rhinitis Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 84 Europe Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR%)
  • Figure 85 "V" Shaped Recovery: Europe Allergic Rhinitis Market Forecast by Sub-Markets, 2020- 2030 (US$ million, AGR%)
  • Figure 86 "U" Shaped Recovery: Europe Allergic Rhinitis Market Forecast by Sub-Markets, 2020- 2030 (US$ million, AGR%)
  • Figure 87 "W" Shaped Recovery: Europe Allergic Rhinitis Market Forecast by Sub-Markets, 2020- 2030 (US$ million, AGR%)
  • Figure 88 "L" Shaped Recovery: Europe Allergic Rhinitis Market Forecast by Sub-Markets, 2020- 2030 (US$ million, AGR%)
  • Figure 89 Germany Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 90 "V" Shaped Recovery: Germany Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 91 "U" Shaped Recovery: Germany Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 92 "W" Shaped Recovery: Germany Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 93 "L" Shaped Recovery: Germany Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 94 UK Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 95 "V" Shaped Recovery: UK Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 96 "U" Shaped Recovery: UK Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 97 "W" Shaped Recovery: UK Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 98 "L" Shaped Recovery: UK Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 99 France Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 100 "V" Shaped Recovery: France Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 101 "U" Shaped Recovery: France Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 102 "W" Shaped Recovery: France Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 103 "L" Shaped Recovery: France Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 104 Italy Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 105 "V" Shaped Recovery: Italy Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 106 "U" Shaped Recovery: Italy Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 107 "W" Shaped Recovery: Italy Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 108 "L" Shaped Recovery: Italy Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 109 Spain Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 110 "V" Shaped Recovery: Spain Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 111 "U" Shaped Recovery: Spain Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 112 "W" Shaped Recovery: Spain Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 113 "L" Shaped Recovery: Spain Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 114 Belgium Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 115 "V" Shaped Recovery: Belgium Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 116 "U" Shaped Recovery: Belgium Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 117 "W" Shaped Recovery: Belgium Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 118 "L" Shaped Recovery: Belgium Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 119 Switzerland Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 120 "V" Shaped Recovery: Switzerland Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 121 "U" Shaped Recovery: Switzerland Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 122 "W" Shaped Recovery: Switzerland Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 123 "L" Shaped Recovery: Switzerland Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 124 Rest of Europe Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 125 "V" Shaped Recovery: Rest of Europe Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 126 "U" Shaped Recovery: Rest of Europe Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 127 "W" Shaped Recovery: Rest of Europe Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 128 "L" Shaped Recovery: Rest of Europe Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 129 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Country 2020-2030 (US$ million, AGR %)
  • Figure 130 Asia Pacific Allergic Rhinitis Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 131 Asia Pacific Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR%)
  • Figure 132 "V" Shaped Recovery: Asia Pacific Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 133 "U" Shaped Recovery: Asia Pacific Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 134 "W" Shaped Recovery: Asia Pacific Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 135 "L" Shaped Recovery: Asia Pacific Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 136 Japan Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 137 "V" Shaped Recovery: Japan Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 138 "U" Shaped Recovery: Japan Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 139 "W" Shaped Recovery: Japan Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 140 "L" Shaped Recovery: Japan Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 141 China Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 142 "V" Shaped Recovery: China Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 143 "U" Shaped Recovery: China Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 144 "W" Shaped Recovery: China Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 145 "L" Shaped Recovery: China Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 146 India Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 147 "V" Shaped Recovery: India Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 148 "U" Shaped Recovery: India Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 149 "W" Shaped Recovery: India Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 150 "L" Shaped Recovery: India Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 151 Rest of Asia Pacific Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 152 "V" Shaped Recovery: Rest of Asia Pacific Allergic Rhinitis Market Forecast, 2020- 2030 (US$ million, AGR%)
  • Figure 153 "U" Shaped Recovery: Rest of Asia Pacific Allergic Rhinitis Market Forecast, 2020- 2030 (US$ million, AGR%)
  • Figure 154 "W" Shaped Recovery: Rest of Asia Pacific Allergic Rhinitis Market Forecast, 2020- 2030 (US$ million, AGR%)
  • Figure 155 "L" Shaped Recovery: Rest of Asia Pacific Allergic Rhinitis Market Forecast, 2020- 2030 (US$ million, AGR%)
  • Figure 156 Latin America Allergic Rhinitis Drugs Market Forecast by Country 2020-2030 (US$ million, AGR %)
  • Figure 157 Latin America Allergic Rhinitis Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 158 Latin America Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR%)
  • Figure 159 "V" Shaped Recovery: Latin America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 160 "U" Shaped Recovery: Latin America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 161 "W" Shaped Recovery: Latin America Allergic Rhinitis Market Forecast by Sub- Markets, 2020-2030 (US$ million, AGR%)
  • Figure 162 "L" Shaped Recovery: Latin America Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 163 Brazil Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 164 "V" Shaped Recovery: Brazil Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 165 "U" Shaped Recovery: Brazil Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 166 "W" Shaped Recovery: Brazil Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 167 "L" Shaped Recovery: Brazil Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 168 Mexico Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 169 "V" Shaped Recovery: Mexico Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 170 "U" Shaped Recovery: Mexico Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 171 "W" Shaped Recovery: Mexico Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 172 "L" Shaped Recovery: Mexico Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 173 Argentina Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 174 "V" Shaped Recovery: Argentina Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 175 "U" Shaped Recovery: Argentina Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 176 "W" Shaped Recovery: Argentina Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 177 "L" Shaped Recovery: Argentina Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 178 Rest of Latin America Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 179 "V" Shaped Recovery: Rest of Latin America Allergic Rhinitis Market Forecast, 2020- 2030 (US$ million, AGR%)
  • Figure 180 "U" Shaped Recovery: Rest of Latin America Allergic Rhinitis Market Forecast, 2020- 2030 (US$ million, AGR%)
  • Figure 181 "W" Shaped Recovery: Rest of Latin America Allergic Rhinitis Market Forecast, 2020- 2030 (US$ million, AGR%)
  • Figure 182 "L" Shaped Recovery: Rest of Latin America Allergic Rhinitis Market Forecast, 2020- 2030 (US$ million, AGR%)
  • Figure 183 MEA Allergic Rhinitis Drugs Market Forecast by Country 2020-2030 (US$ million, AGR %)
  • Figure 184 MEA Allergic Rhinitis Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 185 MEA Allergic Rhinitis Drugs Market Forecast by Sub Markets, 2020-2030 (US$ million, AGR%)
  • Figure 186 "V" Shaped Recovery: Middle East and Africa Allergic Rhinitis Market Forecast by Sub- Markets, 2020-2030 (US$ million, AGR%)
  • Figure 187 "U" Shaped Recovery: Middle East and Africa Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 188 "W" Shaped Recovery: Middle East and Africa Allergic Rhinitis Market Forecast by Sub-Markets, 2020-2030 (US$ million, AGR%)
  • Figure 189 "L" Shaped Recovery: Middle East and Africa Allergic Rhinitis Market Forecast by Sub- Markets, 2020-2030 (US$ million, AGR%)
  • Figure 190 UAE Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 191 "V" Shaped Recovery: UAE Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 192 "U" Shaped Recovery: UAE Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 193 "W" Shaped Recovery: UAE Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 194 "L" Shaped Recovery: UAE Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 195 Saudi Arabia Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 196 "V" Shaped Recovery: Saudi Arabia Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 197 "U" Shaped Recovery: Saudi Arabia Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 198 "W" Shaped Recovery: Saudi Arabia Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 199 "L" Shaped Recovery: Saudi Arabia Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 200 South Africa Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 201 "V" Shaped Recovery: South Africa Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 202 "U" Shaped Recovery: South Africa Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 203 "W" Shaped Recovery: South Africa Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 204 "L" Shaped Recovery: South Africa Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 205 Rest of MEA Allergic Rhinitis Drugs Market Forecast 2020-2030 (US$ million, AGR%)
  • Figure 206 "V" Shaped Recovery: Rest of Middle East and Africa Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 207 "U" Shaped Recovery: Rest of Middle East and Africa Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 208 "W" Shaped Recovery: Rest of Middle East and Africa Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 209 "L" Shaped Recovery: Rest of Middle East and Africa Allergic Rhinitis Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 210 ALK-Abello A/S: Financials, 2015-2019 (DKK million, AGR %)
  • Figure 211 GSK: Financials, 2015-2019 (US$ million, AGR %)
  • Figure 212 Johnson & Johnson: Financials, 2015-2019 (US$ million, AGR %)
  • Figure 213 Kyowa Hakko Kirin: Financials, 2015-2019 (millions of yen, AGR %)
  • Figure 214 Merck KGaA: Financials, 2015-2019 (? million, AGR %)
  • Figure 215 Sanofi: Financials, 2015-2019 (? million, AGR %)
  • Figure 216 Stallergenes Greer: Financials, 2015-2018 (? million, AGR %)
  • Figure 217 UCB S.A.: Financials, 2015-2019 (? million, AGR %)
  • Figure 218 Boehringer Ingelheim International GmbH: Financials, 2015-2019 (? million, AGR %)
  • Figure 219 Bayer AG: Financials, 2015-2019 (? million, AGR %)
  • Figure 220 Novartis AG: Financials, 2015-2019 (US$ million, AGR %)
  • Figure 221 AstraZeneca: Financials, 2015-2019 (US$ million, AGR %)
  • Figure 222 Global Allergic Rhinitis Drugs Market Forecast by Region 2020-2030 (US$ million, AGR %)
  • Figure 223 Global Allergic Rhinitis Drugs Market Share Forecast by Region 2020, 2025, 2030 (%)